Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
341781por Colgrove, Robert, Morin, Scott, Jani, Chinmay, Rupal, Arashdeep, Bourque, Daniel L“…Tocilizumab may be useful in control of pathological inflammation in COVID-19. Controlled trials will be needed to assess overall clinical benefit. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341782por Lasko, Maxwell J, Conelius, Allison, Serrano, Oscar, Nicolau, David P, Kuti, Joseph L“…(Research Grant or Support)Paratek (Speaker’s Bureau)Summit (Other Financial or Material Support, Research funding (clinical trials))…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341783por Barton, Shanna M, Calhoun, Aaron W, Bohnert, Carrie A, Multerer, Sara, Statler, Victoria A, Bryant, Kristina A, Marshall, Gary S“…Bryant, MD, Pfizer (Research Grant or Support, Investigator on multi-center clinical trials) Gary S. Marshall, MD, GlaxoSmithKline (Consultant, Scientific Research Study Investigator)Merck (Consultant, Scientific Research Study Investigator)Pfizer (Consultant, Scientific Research Study Investigator)Sanofi Pasteur (Consultant, Grant/Research Support, Scientific Research Study Investigator, Honorarium for conference lecture)Seqirus (Consultant, Scientific Research Study Investigator)…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341784por Salama, Carlos, Han, Jian, Yau, Linda, Reiss, William G., Kramer, Benjamin, Neidhart, Jeffrey D., Criner, Gerard J., Kaplan-Lewis, Emma, Baden, Rachel, Pandit, Lavannya, Cameron, Miriam L., Garcia-Diaz, Julia, Chávez, Victoria, Mekebeb-Reuter, Martha, Lima de Menezes, Ferdinando, Shah, Reena, González-Lara, Maria F., Assman, Beverly, Freedman, Jamie, Mohan, Shalini V.“…(Funded by Genentech; EMPACTA ClinicalTrials.gov number, NCT04372186.)…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341785por Subhan, Bibi S., Kwong, Jennifer, Kuhn, Joseph F., Monas, Arie, Sharma, Sonali, Rabbani, Piul S.“…In addition, investigations concerning safety and efficacy of this therapy in clinical trials should be pursued.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341786por Altcheh, Jaime, Castro, Luis, Dib, Juan C., Grossmann, Ulrike, Huang, Erya, Moscatelli, Guillermo, Pinto Rocha, Jimy José, Ramírez, Teresa Estela“…In this blinded, controlled study conducted January 2016–July 2018, 330 patients aged <18 years from 25 medical centres across three South American countries were randomised 2:1 to nifurtimox 10–20 mg/kg/day (aged <12 years) or 8–10 mg/kg/day (aged ≥12 years) for 60 days (n = 219), or for 30 days plus placebo for 30 days (n = 111) (ClinicalTrials.gov NCT02625974). The primary outcome was anti-Trypanosoma cruzi serological response (negative seroconversion or seroreduction ≥20% in mean optical density from baseline determined by two conventional enzyme-linked immunosorbent assays) at 12 months in the 60-day treatment group versus historical placebo controls. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341787por Manwani, Bharti, Fall, Pamela, Zhu, Liang, O’Reilly, Meaghan Roy, Conway, Sarah, Staff, Ilene, McCullough, Louise D.“…BACKGROUND: Sex differences in stroke have been attributed to the neuroprotective effects of estrogen, yet most clinical trials of estrogen supplementation for stroke prevention have failed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341788“…In addition to the practical and clinical difficulties with early diagnosis of sepsis, recent clinical trials have shown higher morbidity and mortality when septic patients are over-resuscitated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341789por Bruni, Alessio, Stefani, Alessandro, Perna, Marco, Borghetti, Paolo, Giaj Levra, Niccolò, D’Angelo, Elisa, D’Onofrio, Alessandra, Rubino, Laura, Frassinelli, Luca, Salvestrini, Viola, Mariotti, Matteo, Alongi, Filippo, Gonfiotti, Alessandro, Livi, Lorenzo, Scotti, Vieri“…High grade acute toxicity was not different between PORT and surgery alone. Other trials reported a significant benefit in OS, DSS and DFS in stage IIb–IV thymoma treated with PORT.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341790por Reese, Thomas J., Schlechter, Chelsey R., Potter, Lindsey N., Kawamoto, Kensaku, Del Fiol, Guilherme, Lam, Cho Y., Wetter, David W.“…IMPORTANCE: Lung cancer incidence and mortality disproportionately affect women and racial/ethnic minority populations, yet screening guidelines for the past several years were derived from clinical trials of predominantly White men. To reflect current evidence, the US Preventive Services Task Force (USPSTF) has revised the eligibility criteria, which may help to ameliorate sex- and race/ethnicity–related disparities in lung cancer screening. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341791por Chen, Yudi, Yu, Miao, Huang, Xiaojie, Tu, Ping, Shi, Peikun, Maurer, Marcus, Zhao, Zuotao“…Omalizumab is effective and safe for difficult-to-treat CSU based on clinical trials. However, there are limited data comparing the therapeutic effect of omalizumab for patients with CSU, CIndU, and CSU plus CIndU. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341792por Yang, Jiang, Zhao, Chunhua, Lim, Jacky, Zhao, Lina, Tourneau, Ryan Le, Zhang, Qize, Dobson, Damien, Joshi, Suhasini, Pang, Jiadong, Zhang, Xiaodong, Pal, Suchetan, Andreou, Chrysafis, Zhang, Hanwen, Kircher, Moritz F., Schmitthenner, Hans“…Alternative near-infrared (NIR) dyes including IRDye800cw are being explored in advanced clinical trials but often encounter low chemical yields and complex purifications owing to the asymmetric synthesis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341793por Pepic, Ivana, Feldt, Robert, Ljungström, Lars, Torkar, Richard, Dalevi, Daniel, Maurin Söderholm, Hanna, Andersson, Lars-Magnus, Axelson-Fisk, Marina, Bohm, Katarina, Sjöqvist, Bengt Arne, Candefjord, Stefan“…Furthermore, clinical studies that have completed patient recruitment and reported results found in the database ClinicalTrials.gov will be considered. The term artificial intelligence is viewed broadly, and a wide range of machine learning and mathematical models suitable as base for decision support will be evaluated. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341794por Bhattacharyya, Arinjita, Seth, Anand, Srivastava, Niharika, Imeokparia, Michael, Rai, Shesh“…Following the recent FDA’s guidance for designing Covid-19 vaccine trials, stratification factors of age, race, sex, and comorbidities need consideration in allocation. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341795por Jiskoot, Lize C., Poos, Jackie M., Vollebergh, Manon E., Franzen, Sanne, van Hemmen, Judy, Papma, Janne M., van Swieten, John C., Kessels, Roy P. C., van den Berg, Esther“…This highlights the importance of incorporating emotion recognition paradigms into standard neuropsychological assessment for early differential diagnosis, and as clinical endpoints in upcoming therapeutic trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00415-020-10096-y) contains supplementary material, which is available to authorized users.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341796“…Moreover, the efficiency of SNF-NN is verified by validating predicted unknown drug-disease interactions against clinical trials and published studies. CONCLUSION: In conclusion, computational drug repositioning research can significantly benefit from integrating similarity measures in heterogeneous networks and deep learning models for predicting novel drug-disease interactions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341797por San Norberto, EM, De Haro, J, Peña, R, Riera, L, Fernández-Caballero, D, Sesma, A, Rodríguez-Cabeza, P, Ballesteros, M, Gómez-Jabalera, E, Taneva, GT, Aparicio, C, Moradillo, N, Soguero, I, Badrenas, AM, Lara, R, Torres, A, Sala, VA, Vaquero, C“…The primary end point was 30-day mortality. Clinical Trials registry number NCT04333693. RESULTS: The mean age was 70.9 (45–94) and 58 (77.0%) patients were male. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341798por Fountzilas, Elena, Eliades, Alexia, Koliou, Georgia-Angeliki, Achilleos, Achilleas, Loizides, Charalambos, Tsangaras, Kyriakos, Pectasides, Dimitrios, Sgouros, Joseph, Papakostas, Pavlos, Rallis, Grigorios, Psyrri, Amanda, Papadimitriou, Christos, Oikonomopoulos, Georgios, Ferentinos, Konstantinos, Koumarianou, Anna, Zarkavelis, George, Dervenis, Christos, Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Kosmidis, Paris, Papaxoinis, George, Theochari, Maria, Varthalitis, Ioannis, Kentepozidis, Nikolaos, Rigakos, Georgios, Saridaki, Zacharenia, Nikolaidi, Adamantia, Christopoulou, Athina, Fostira, Florentia, Samantas, Epaminontas, Kypri, Elena, Ioannides, Marios, Koumbaris, George, Fountzilas, George, Patsalis, Philippos C.“…The predictive role of these P/LPVs has yet to be defined. ClinicalTrials.gov Identifier: NCT03982446.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341799por Cho, Byung-Sik, Min, Gi-June, Park, Sung-Soo, Park, Silvia, Jeon, Young-Woo, Shin, Seung-Hwan, Yahng, Seung-Ah, Yoon, Jae-Ho, Lee, Sung-Eun, Eom, Ki-Seong, Kim, Yoo-Jin, Lee, Seok, Min, Chang-Ki, Cho, Seok-Goo, Kim, Dong-Wook, Wook-Lee, Jong, Kim, Myung-Shin, Kim, Yong-Goo, Kim, Hee-Je“…Very poor outcomes of pre-transplant MRD-positive patients with D816V KIT mutation suggested that this group should be treated in clinical trials. Risk stratification by both D816V KIT mutation and RUNX1–RUNX1T1 MRD status will provide a platform for decision-making or risk-adapted therapeutic approaches.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
341800por El-Ashmawy, Nahla E., Lashin, Abdel-Halim A., Okasha, Kamal M., Abo Kamer, Amal M., Mostafa, Tarek M., El-Aasr, Mona, Goda, Ahmed E., Haggag, Yusuf A., Tawfik, Haytham O., Abo-Saif, Mariam A.“…Based on that, tramadol should be considered as adjuvant therapy for COVID-19 clinical trials.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto